S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
ASX:CGS

Cogstate Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,002 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive CGS News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogstate and its competitors with MarketBeat's FREE daily newsletter.


About Cogstate

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2020, it had participated in approximately 1,800 academic research studies in approximately 200 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is based in Fitzroy, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$32.69 million
Book Value
A$0.13 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

Company Calendar

Today
12/04/2021
Next Earnings (Estimated)
2/23/2022

MarketRank

Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Cogstate (ASX:CGS) Frequently Asked Questions

When is Cogstate's next earnings date?

Cogstate is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Cogstate
.

Who are Cogstate's key executives?

Cogstate's management team includes the following people:
  • Mr. Bradley O'Connor C.A., B.Bus, CA, CEO, MD & Exec. Director
  • Prof. Paul Maruff, Founder & Chief Innovation Officer
  • Mr. John Glueck B.A., J.D., Gen. Counsel
  • Mr. Kenneth Billard, Chief Commercial Officer
  • Mr. Darren Watson, Chief Financial Officer
  • Mr. Benjamin Bloomfield, Chief Technology Officer
  • Dr. Chris Edgar Ph.D., Chief Science Officer
  • Ms. Rachel Colite, VP of Strategic Initiatives, Communication & People
  • Mr. Keith Hawkins CPA, Financial Controller
  • Mr. David James Franks B.Ec, BEc, CA, F Fin, JP., Company Sec. (Age 51)

What is Cogstate's stock symbol?

Cogstate trades on the ASX under the ticker symbol "CGS."

How much money does Cogstate make?

Cogstate has a market capitalization of $0.00 and generates $32.69 million in revenue each year.

How many employees does Cogstate have?

Cogstate employs 163 workers across the globe.

What is Cogstate's official website?

The official website for Cogstate is www.cogstate.com.

How can I contact Cogstate?

The company can be reached via phone at 61 3 9664 1300.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.